Methylene blue-mediated photodynamic therapy enhances apoptosis in lung cancer cells

Lim,Eun  Jin; Oak,Chul-Ho; Heo,Jeonghoon; Kim,Young-Ho

doi:10.3892/or.2013.2494

Methylene blue-mediated photodynamic therapy enhances apoptosis in lung cancer cells

Authors:
- Eun Jin Lim
- Chul-Ho Oak
- Jeonghoon Heo
- Young-Ho Kim
View Affiliations

Affiliations: Department of Molecular Biology and Immunology, Kosin University College of Medicine, Busan, Republic of Korea, Department of Internal Medicine, Kosin University College of Medicine, Busan, Republic of Korea
Published online on: May 24, 2013 https://doi.org/10.3892/or.2013.2494
Pages: 856-862

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Combined treatment with a photosensitizer and iodide laser [photodynamic therapy (PDT)] has improved the outcome of various cancers. In this study, we investigated the effects of using the photosensitizer methylene blue (MB) in PDT in human lung adenocarcinoma cells. We found that MB enhances PDT-induced apoptosis in association with downregulation of anti-apoptotic proteins, reduced mitochondrial membrane potential (MMP), increased phosphorylation of the mitogen-activated protein kinase (MAPK) and the generation of reactive oxygen species (ROS). In MB-PDT-treated A549 cells, we observed PARP cleavage, procaspase-3 activation, downregulation of the anti-apoptotic proteins Bcl-2 and Mcl-1, and the reduction of mitochondrial membrane potential (MMP). Western blot data showed that phosphorylation of p38 was increased in MB-PDT-treated A549 cells, indicating that several signaling molecules participate in the apoptotic cascade. Our data also showed that apoptotic cell death in MB-PDT-treated cells occurred through a series of steps beginning with the photochemical generation of ROS. Demonstrating the role of ROS, pretreatment of A549 cells with the antioxidant N-acetylcysteine (NAC) followed by MB-PDT resulted in increased cell viability and reduced proteolytic cleavage of PARP.

View Figures

View References

1	Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q: Photodynamic therapy. J Natl Cancer Inst. 90:889–905. 1998. View Article : Google Scholar
2	Dolmans DE, Fukumura D and Jain RK: Photodynamic therapy for cancer. Nat Rev Cancer. 3:380–387. 2003. View Article : Google Scholar
3	Sharman WM, Allen CM and van Lier JE: Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today. 4:507–517. 1999. View Article : Google Scholar : PubMed/NCBI
4	Bisland SK, Chien C, Wilson BC and Burch S: Pre-clinical in vitro and in vivo studies to examine the potential use of photodynamic therapy in the treatment of osteomyelitis. Photochem Photobiol Sci. 5:31–38. 2006. View Article : Google Scholar : PubMed/NCBI
5	Tardivo JP, Del Giglio A, Paschoal LH and Baptista MS: New photodynamic therapy protocol to treat AIDS-related Kaposi's sarcoma. Photomed Laser Surg. 24:528–531. 2006. View Article : Google Scholar : PubMed/NCBI
6	Wagner M, Suarez ER, Theodoro TR, Machado Filho CD, Gama MF, Tardivo JP, Paschoal FM and Pinhal MA: Methylene blue photodynamic therapy in malignant melanoma decreases expression of proliferating cell nuclear antigen and heparanases. Clin Exp Dermatol. 37:527–533. 2012. View Article : Google Scholar
7	Kirszberg C, Rumjanek VM and Capella MA: Methylene blue is more toxic to erythroleukemic cells than to normal peripheral blood mononuclear cells: a possible use in chemotherapy. Cancer Chemother Pharmacol. 56:659–665. 2005. View Article : Google Scholar : PubMed/NCBI
8	Ball DJ, Luo Y, Kessel D, Griffiths J, Brown SB and Vernon DI: The induction of apoptosis by a positively charged methylene blue derivative. J Photochem Photobiol B. 42:159–163. 1998. View Article : Google Scholar : PubMed/NCBI
9	Noodt BB, Rodal GH, Wainwright M, Peng Q, Horobin R, Nesland JM and Berg K: Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int J Cancer. 75:941–948. 1988. View Article : Google Scholar : PubMed/NCBI
10	Rodrigues T, de França LP, Kawai C, de Faria PA, Mugnol KC, Braga FM, Tersariol IL, Smaili SS and Nantes IL: Protective role of mitochondrial unsaturated lipids on the preservation of the apoptotic ability of cytochrome C exposed to singlet oxygen. J Biol Chem. 282:25577–25587. 2007. View Article : Google Scholar : PubMed/NCBI
11	Gabrielli D, Belisle E, Severino D, Kowaltowski AJ and Baptista MS: Binding, aggregation and photochemical properties of methylene blue in mitochondrial suspensions. Photochem Photobiol. 79:227–232. 2004. View Article : Google Scholar : PubMed/NCBI
12	Chen Y, Zheng W, Li Y, Zhong J, Ji J and Shen P: Apoptosis induced by methylene-blue-mediated photodynamic therapy in melanomas and the involvement of mitochondrial dysfunction revealed by proteomics. Cancer Sci. 99:2019–2027. 2008.PubMed/NCBI
13	Lu Y, Jiao R, Chen X, Zhong J, Ji J and Shen P: Methylene blue-mediated photodynamic therapy induces mitochondria-dependent apoptosis in HeLa cell. J Cell Biochem. 105:1451–1460. 2008. View Article : Google Scholar : PubMed/NCBI
14	Kim MJ, Lee TH, Kim SH, Choi YJ, Heo J and Kim YH: Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway. Int J Oncol. 37:1177–1185. 2010.PubMed/NCBI
15	Szatrowski TP and Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51:794–798. 1991.PubMed/NCBI
16	Simon HU, Haj-Yehia A and Levi-Schaffer F: Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 5:415–418. 2000. View Article : Google Scholar : PubMed/NCBI
17	Firczuk M, Winiarska M, Szokalska A, Jodlowska M, Swiech M, Bojarczuk K, Salwa P and Nowis D: Approaches to improve photodynamic therapy of cancer. Front Biosci. 16:208–224. 2011. View Article : Google Scholar : PubMed/NCBI
18	Nahabedian MY, Cohen RA, Contino MF, Terem TM, Wright WH, Berns MW and Wile AG: Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. J Natl Cancer Inst. 80:739–743. 1988. View Article : Google Scholar : PubMed/NCBI
19	Peng Q, Warloe T, Moan J, Godal A, Apricena F, Giercksky KE and Nesland JM: Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. Cancer Res. 61:5824–5832. 2001.PubMed/NCBI
20	Sherlock DJ and Holl-Allen RT: Intravital methylene blue staining of parathyroid glands and tumours. Ann R Coll Surg Engl. 66:396–398. 1984.PubMed/NCBI
21	Meissner PE, Mandi G, Coulibaly B, Witte S, Tapsoba T, Mansmann U, Rengelshausen J, Schiek W, Jahn A, Walter-Sack I, Mikus G, Burhenne J, Riedel KD, Schirmer RH, Kouyaté B and Müller O: Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar J. 5:842006. View Article : Google Scholar : PubMed/NCBI
22	Yang ES, Choi MJ, Kim JH, Choi KS and Kwon TK: Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells. Toxicol In Vitro. 25:1803–1810. 2011. View Article : Google Scholar : PubMed/NCBI
23	Chen YR and Tan TH: The c-Jun N-terminal kinase pathway and apoptotic signaling. Int J Oncol. 16:651–662. 2000.PubMed/NCBI